European molecular imaging markets reached $276 million in 2011 and could produce revenues of $388 million in 2018, according to a report from Frost & Sullivan. The report predicts that Italy, Scandinavia and the Benelux region (Belgium, the Netherlands and Luxembourg) will show the earliest growth, followed by France and Spain. Growth will be driven by the increasing adoption of molecular imaging in neurology and the development of advanced modalities such as PET/MR, the report said.

Full Story:

Related Summaries